IN8bio, Inc. (INAB)
NASDAQ: INAB · Real-Time Price · USD
1.940
-0.050 (-2.51%)
Mar 12, 2026, 3:20 PM EDT - Market open
IN8bio Market Cap
IN8bio has a market cap or net worth of $18.95 million as of March 12, 2026. Its market cap has increased by 2.47% in one year.
Market Cap
18.95M
Enterprise Value
11.12M
1-Year Change
2.47%
Ranking
Category
Stock Price
$1.94
Market Cap Chart
Since the IPO on July 30, 2021, IN8bio's market cap has decreased from $187.55M to $18.95M, a decrease of -89.90%. That is a compound annual growth rate of -39.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 11, 2026 | 19.43M | 96.89% |
| Dec 31, 2025 | 9.87M | -47.05% |
| Dec 31, 2024 | 18.64M | -68.76% |
| Dec 29, 2023 | 59.67M | 5.43% |
| Dec 30, 2022 | 56.60M | -31.25% |
| Dec 31, 2021 | 82.33M | -56.10% |
| Jul 30, 2021 | 187.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Polyrizon | 20.90M |
| IO Biotech | 20.85M |
| NanoViricides | 20.77M |
| Allarity Therapeutics | 20.74M |
| Genenta Science | 19.92M |
| VYNE Therapeutics | 19.75M |
| Intensity Therapeutics | 19.62M |
| Longeveron | 18.67M |